The restoration of IRS-1 expression and the downregulation of insulin resistance markers highlight the potential of hesperidin as a promising therapeutic intervention to counter the negative impact of liver insulin resistance caused by IL-6. The gene discussed is IL6; the disease is Insulin resistance.